GlassScriptPhysician profile
Ingrid J Ortiz
NPI 1225669138
$9,394.64
in general payments reported to CMS, 2019-2025
36 companies · $2,228 in 2025
The $2,228 reported for 2025 was more than what 96% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $711 · 2022: $484 · 2023: $3,267 · 2024: $2,705 · 2025: $2,228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,773 · Travel and Lodging: $1,169 · Education: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,772.92 |
| Travel and Lodging | $1,169.10 |
| Education | $257.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,582.28 | 2023-2024 | Axonics |
| Astellas Pharma US INC | $1,550.96 | 2021-2025 | Xtandi, Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $1,319.24 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $575.72 | 2023-2025 | |
| Pfizer INC. | $533.22 | 2023-2025 | |
| Coloplast Corp | $402.40 | 2021-2025 | Speedicath |
| Bayer Healthcare Pharmaceuticals INC. | $380.14 | 2022-2025 | |
| Endo USA, INC. | $366.82 | 2024-2025 | Xiaflex, Aveed |
| Progenics Pharmaceuticals, INC. | $265.68 | 2023-2025 | Pylarify |
| Antares Pharma, INC. | $231.07 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $209.44 | 2023-2025 | Keytruda, Welireg, Lynparza |
| Urovant Sciences INC | $199.48 | 2021-2022 | |
| Blue Earth Diagnostics | $196.63 | 2023-2025 | Posluma |
| Urogen Pharma, INC. | $189.34 | 2023-2025 | Jelmyto |
| Endo Pharmaceuticals INC. | $146.71 | 2023-2024 | Xiaflex, Aveed |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Clarus Therapeutics INC. | $142.60 | 2021 | |
| Accord Healthcare, INC. | $131.06 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $118.80 | 2025 | Cobenfy |
| Procept Biorobotics Corporation | $105.90 | 2023-2024 | Aquabeam Robotic System, Aquabeam System |
| C. R. Bard, INC. & Subsidiaries | $86.30 | 2023-2024 | |
| Janssen Biotech, INC. | $76.43 | 2025 | Erleada |
| 180 Medical, INC. | $64.71 | 2021 | |
| Alnylam Pharmaceuticals INC. | $58.49 | 2022 | |
| Boston Scientific Corporation | $56.45 | 2023-2025 | Lithovue |
| Teleflex LLC | $51.78 | 2022-2023 | Urolift |
| Immunitybio, INC. | $51.05 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $49.33 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $46.61 | 2021 | |
| Azurity Pharmaceuticals, INC. | $40.31 | 2025 | Azmiro |
| Ambu INC. | $40.18 | 2024 | |
| Novo Nordisk INC | $38.41 | 2024 | Rivfloza |
| Telix Pharmaceuticals | $20.22 | 2024 | Illuccix |
| Abc Home Medical Supply, INC. | $19.72 | 2025 | |
| Tolmar, INC. | $18.95 | 2025 | Eligard |
| Innovation Technologies INC | $14.87 | 2024 | Irrisept |
| Hollister Incorporated | $13.34 | 2023 | Infyna Chic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ingrid Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.